Digital Wellbeing to Participate in Microdose Psychedelic Capital . Conference

Digital Wellbeing to Participate in Microdose Psychedelic Capital . Conference

Vancouver, British Columbia–(work wire) – Wellbeing Digital Sciences Inc. (“luxury “ or the “a company‘) (NEO: midi) (Off the stock exchange: Conf) (France: SQ2), an evidence-based mental healthcare company focused on developing and implementing innovative clinical solutions, including psychedelic medicine and digital therapies as supported by clinical research, announces that Naglaa Guthrie, CEO of Wellbeing, will participate in Microdose’s Psychedelic Capital: September 2022 conference will be held By default on September 29, 2022 at 1:30 PM ET.

Najla Guthrie will participate in “Psychedelic patents: navigating the controversial IP landscapeTeam. Register to attend over here.

For more information about the conference, or to schedule a one-on-one meeting with the Wellbeing management team, please email Natalie Dolphin at ndolphin@wellbeingdigital.co.

About Compassionate Digital Science

Wellbeing Digital Sciences Inc. is an evidence-based mental health care company focused on developing and implementing innovative clinical treatment solutions, including psychedelic medicine and digital therapies, as backed by clinical research. Its mission is supported by a network of North American clinics that provide forward-looking therapies and other types of treatment to patients as well as by a contract research organization that provides clinical trial services to clients pursuing drug development. For additional information, please visit wellbeingdigital.co.

On behalf of:

Naglaa Guthrie

chief executive officer

Health Digital Science

Notice regarding forward-looking information:

This news release contains forward-looking statements, including but not limited to statements regarding the Company’s business, assets or investments, as well as other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no guarantee of occurrence of the plans, intentions or expectations on which they are based. By their nature, forward-looking statements involve many assumptions, known and unknown risks and uncertainties, general and specific, that contribute to the possibility that predictions, forecasts, projections and other forward-looking statements may not occur, which may cause an actual occurrence. Performance and results in future periods may differ materially from any estimates or expectations of future performance or results expressed or implied in these forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, and investors’ interest in the company’s business and prospects.

The forward-looking statements contained in this press release are made as of the date of this press release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. In addition, the Company undertakes no obligation to comment on forecasts or statements made by third parties in connection with the matters discussed above.

#Digital #Wellbeing #Participate #Microdose #Psychedelic #Capital #Conference

Leave a Comment

Your email address will not be published.